ISSN 1694-8882 / e-ISSN 1694-8890
Vol. 17, No. 4, 2025 / Pages 199-212

Prevalence of osteoporosis among residents living at different altitudes in Kyrgyzstan

Received 13.07.2025
Revised 12.11.2025
Accepted 25.12.2025

Abstract

Osteoporosis is a substantial health problem among people, which highlights the importance of studying its prevalence in different geographical regions. The study aimed to assess the prevalence of osteoporosis among population living at different altitudes in Kyrgyz Republic. The study included patients from three regions of Kyrgyz Republic. Baseline data were collected from populations of Bishkek (760 m) (Chui Region), Naryn (2,020 m) (Naryn Region) and Karakol (1,650 m) (Issyk-Kul Region) between July 2022 and August 2024. To assess differences in incidence of osteoporosis among populations living at different altitudes and with different characteristics, authors used chi-square test and rank sum test. A total of 2,300 people participated in study, including 850 lowland residents (Bishkek, 760 m above sea level), 750 residents of mid-mountain region (Karakol, 1,760 m above sea level) and 700 residents of high-mountain region (Naryn, 2,020 m above sea level). Prevalence of osteopenia in mid-altitude and high-altitude regions was 33.7% and 25.2%, respectively, while prevalence of osteoporosis varied significantly: 22.3% in mid-altitude areas compared to 14.9% in high-altitude areas (p < 0.002). Further analysis revealed statistically significant differences in prevalence of osteopenia and osteoporosis among women (p < 0.05), elderly people (p < 0.05), as well as among underweight individuals (p < 0.01), normal weight individuals (p < 0.05) and obese individuals (p < 0.03). With increasing height, prevalence of osteoporosis decreased in all groups, while prevalence of osteopenia decreased among women and in various body mass index categories, but increased among young and elderly people. This study demonstrates that higher altitudes are associated with a lower prevalence of osteopenia and osteoporosis, especially among women and middle-aged and elderly people

Keywords

osteoporosis; ageing; prevalence; altitude above sea level; Kyrgyzstan

Suggested citation

APA Style
Tagayeva, B., Tagayev, T., Turatbekova, A. & Imanalieva, F. (2025). Prevalence of osteoporosis among residents living at different altitudes in Kyrgyzstan. Eurasian Health Journal, 17(4), 199-212. https://doi.org/10.54890/1694-8882-2025-4-199
Copied!
Vancouver Style
Tagayeva, B., Tagayev, T., Turatbekova, A., Imanalieva, F.. Prevalence of osteoporosis among residents living at different altitudes in Kyrgyzstan. Eurasian Health J. 2025;17(4):199-212. https://doi.org/10.54890/1694-8882-2025-4-199
Copied!

References

  1. Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan TA, Cooney TG. Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: A living clinical guideline from the American College of Physicians (version 1, update alert). Ann Intern Med. 2024;177(6):eL230113. DOI: 10.7326/L240113
  2. Geusens P, Bours SPG, Wyers CE, van den Bergh JP. Fracture liaison programs. Best Pract Res Clin Rheumatol. 2019;33(2):278–89. DOI: 10.1016/j.berh.2019.03.016
  3. Rajnish RK, Elhence A, Jha SS, Dhanasekararaja P. Pain management in osteoporosis. Indian J Orthop. 2023;57(Suppl 1):230–6. DOI: 10.1007/s43465-023-01047-6
  4. Kashfi SS, Abdollahi G, Hassanzadeh J, Mokarami H, Khani Jeihooni A. The relationship between osteoporosis and depression. Sci Rep. 2022;12(1):11177. DOI: 10.1038/s41598-022-15248-w
  5. Wang P, Abdin E, Shafie S, Chong SA, Vaingankar JA, Subramaniam M. Estimation of prevalence of osteoporosis using OSTA and its correlation with sociodemographic factors, disability and comorbidities. Int J Environ Res Public Health. 2019;16(13):2338. DOI: 10.3390/ijerph16132338
  6. Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, et al. SCOPE 2021: A new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16(1):82. DOI: 10.1007/s11657-020-00871-9
  7. Freemantle N, Cooper C, Diez-Perez A, Gitlin M, Radcliffe H, Shepherd S, et al. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: A meta-analysis. Osteoporos Int. 2013;24:209–17. DOI: 10.1007/s00198-012-2068-9
  8. Taguchi A, Tanaka S, Ozaki T, Arai K, Mori S, Ohta H, et al. Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese osteoporosis intervention trial-05 (JOINT-05). J Bone Miner Metab. 2023;41:854–64. DOI: 10.1007/s00774-023-01466-3
  9. Anupama DS, Noronha JA, Prabhu KKV, Mukhyaprana, Ravishankar N, Nayak BS. Effect of lifestyle modification intervention programme on bone mineral density among postmenopausal women with osteoporosis. Sultan Qaboos Univ Med J. 2023;23(3):387–93. DOI: 10.18295/squmj.1.2023.010
  10. Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, et al. Prevalence of osteoporosis and fracture in China: The China osteoporosis prevalence study. JAMA Netw Open. 2021;4(8):e2121106. DOI: 10.1001/ jamanetworkopen.2021.21106
  11. Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ. Projection of osteoporosis-related fractures and costs in China: 2010-2050. Osteoporos Int. 2015;26(7):1929–37. DOI: 10.1007/s00198-015-3093-2
  12. Yan C, Wang Z, Liu W, Pu L, Li R, Ai C, et al. Resveratrol ameliorates high altitude hypoxia-induced osteoporosis by suppressing the ROS/HIF signaling pathway. Molecules. 2022;27(17):5538. DOI: 10.3390/ molecules27175538
  13. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6):1678–88. DOI: 10.1093/ajcn/80.6.1678S
  14. Serrat MA. Environmental temperature impact on bone and cartilage growth. Compr Physiol. 2014;4(2):621–55. DOI: 10.1002/cphy.c130023
  15. Imanalieva FE, Tagaev TJ, Marishbek E, Mamatov SM. Bone mineral density measured by ultrasound densitometry in adult population of the Kyrgyz Republic. Clin Gerontol. 2022;28(5–6):63–8. DOI: 10.26347/16072499202205-06063-068
  16. Tagaev T, Imanalieva F, Mamatov S, Marishbek kyzy E, Tagaeva BT. Prevalence of osteopenic syndrome and osteoporosis among residents of the older age group of Kyrgyzstan. Acta Biomed Sci. 2022;7(4):130–7.
  17. World Medical Association. World medical association declaration of Helsinki: Ethical principles for medical research involving human participants. JAMA. 2025;333(1):71–4. DOI: 10.1001/jama.2024.21972
  18. Zhang F, Chen Y, Wang S, Shi Z, Zhong Y, Zhu S, et al. Impact of altitude on the development of low bone mineral density and osteoporosis in individuals aged 50 years and older: Protocol for a multicentre prospective cohort study. BMJ Open. 2024;14(8):e087142. DOI: 10.1136/bmjopen-2024-087142
  19. Singh S, Sarma DK, Verma V, Nagpal R, Kumar M. From cells to environment: Exploring the interplay between factors shaping bone health and disease. Medicina. 2023;59(9):1546. DOI: 10.3390/medicina59091546
  20. Vatanparast H, Lane G, Islam N, Patil RP, Shafiee M, Whiting SJ. Comparative analysis of dietary and supplemental intake of calcium and vitamin D among Canadian older adults with heart disease and/or osteoporosis in 2004 and 2015. Nutrients. 2023;15(24):5066. DOI: 10.3390/nu15245066
  21. Ansari S, Abbasi B, Saneei P, Heidari Z, Saraf-Bank S. Higher lacto-vegetarian dietary score is associated with reduced risk of postmenopausal osteoporosis: A case-control study in a sample of Iranian postmenopausal women. Nutr Res. 2023;120:88–98. DOI: 10.1016/j.nutres.2023.08.003
  22. Wang CC, Yeh HY, Popov AN, Zhang HQ, Matsumura H, Sirak K, et al. Genomic insights into the formation of human populations in East Asia. Nature. 2021;591(7850):413–9. DOI: 10.1038/s41586-021-03336-2